Agios Pharmaceuticals Inc (AGIO)
$30.55 -17.94% Close Oct 30, 2026 Live
Agios Pharmaceuticals stock today
Agios Pharmaceuticals closed at $30.55 on October 30, 2026, down 17.94% on the day. Over the past year it returned -29.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.82 billion.
$30.00$40.00
NovJan 2026MarMayJulSep
| Period | AGIO | S&P 500 (SPY) |
|---|---|---|
| 1 month | -8.1% | -0.9% |
| 3 months | -6.7% | +2.1% |
| Year to date | +12.2% | +11.7% |
| 1 year | -29.2% | +12.4% |
| 3 years | +49.8% | +88.5% |
| 5 years | -35.0% | +76.0% |
Key statistics
- Market value
- $1.82B
- Price / sales
- 18.5
- 52-week range
- $22.34 to $45.49
- Next report
- Nov 5, 2026
About Agios Pharmaceuticals
Develops and commercializes pharmaceutical therapies for rare and orphan genetic diseases.
Sector: Health Care
More on Agios Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +48% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $628.86 today
No forecast, no recommendation. This page describes Agios Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.